ShuYu Civilian Pharmacy Corp., Ltd. (SHE:301017)
China · Delayed Price · Currency is CNY 12.17
0.00 (0.00%)
At close: Sep 16, 2026
SHE:301017 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,936 | 5,935 | 4,808 | 8,281 | 7,292 | 9,789 | |
Market Cap Growth | 4.23% | 23.43% | -41.94% | 13.56% | -25.51% | - |
Enterprise Value | 6,841 | 8,229 | 7,477 | 10,379 | 8,406 | 9,822 |
Last Close Price | 12.17 | 14.70 | 11.91 | 20.26 | 17.73 | 23.70 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 49.42 | 51.96 | - | 62.24 | 31.78 | 85.18 |
Forward PE | - | 27.41 | 27.41 | 27.41 | 27.41 | 32.64 |
PS Ratio | 0.46 | 0.57 | 0.50 | 0.90 | 0.93 | 1.84 |
PB Ratio | 2.19 | 2.59 | 2.26 | 3.50 | 3.22 | 5.11 |
P/TBV Ratio | - | - | 30.48 | 10.66 | 6.37 | 8.49 |
P/FCF Ratio | 8.38 | 9.41 | 15.23 | - | 191.93 | 97.00 |
P/OCF Ratio | 6.96 | 7.39 | 9.83 | 57.95 | 49.12 | 41.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 0.64 | 0.80 | 0.78 | 1.13 | 1.07 | 1.85 |
EV/EBITDA Ratio | 11.40 | 32.43 | 121.30 | 28.84 | 19.10 | 44.79 |
EV/EBIT Ratio | 31.71 | 40.68 | - | 35.55 | 22.02 | 56.59 |
EV/FCF Ratio | 11.61 | 13.05 | 23.68 | - | 221.23 | 97.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 1.46 | 1.34 | 1.87 | 1.64 | 1.31 | 0.65 |
Debt / EBITDA Ratio | 5.49 | 5.06 | 8.48 | 4.83 | 3.92 | 2.84 |
Debt / FCF Ratio | 5.59 | 4.87 | 12.60 | - | 77.96 | 12.25 |
Net Debt / Equity Ratio | 0.81 | 0.80 | 1.21 | 1.00 | 0.49 | 0.26 |
Net Debt / EBITDA Ratio | 6.85 | 7.20 | 41.75 | 6.60 | 2.50 | 2.25 |
Net Debt / FCF Ratio | 3.11 | 2.90 | 8.15 | -61.48 | 28.99 | 4.88 |
Asset Turnover | 1.10 | 1.11 | 1.03 | 1.07 | 1.22 | 1.32 |
Inventory Turnover | 3.95 | 4.04 | 3.62 | 3.42 | 3.70 | 3.56 |
Quick Ratio | 0.49 | 0.48 | 0.54 | 0.55 | 0.66 | 0.48 |
Current Ratio | 0.89 | 0.91 | 0.99 | 1.05 | 1.18 | 1.04 |
Return on Equity (ROE) | 5.15% | 5.29% | -9.13% | 6.04% | 11.16% | 6.64% |
Return on Assets (ROA) | 1.38% | 1.35% | -0.09% | 2.12% | 3.71% | 2.69% |
Return on Invested Capital (ROIC) | 3.42% | 3.12% | -0.29% | 5.68% | 9.62% | 7.58% |
Return on Capital Employed (ROCE) | 5.80% | 5.20% | -0.40% | 7.20% | 10.40% | 7.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.10% | 1.93% | -3.93% | 1.61% | 3.15% | 1.17% |
FCF Yield | 11.94% | 10.62% | 6.57% | -0.47% | 0.52% | 1.03% |
Dividend Yield | 0.34% | 0.31% | - | 0.25% | 0.65% | 0.31% |
Payout Ratio | 107.49% | 79.03% | - | 80.48% | 30.46% | 48.48% |
Buyback Yield / Dilution | -4.95% | -1.56% | 0.37% | -0.17% | -5.07% | -4.47% |
Total Shareholder Return | -4.61% | -1.25% | 0.37% | 0.07% | -4.42% | -4.16% |